1.53
price up icon1.32%   0.02
after-market アフターアワーズ: 1.53
loading
前日終値:
$1.51
開ける:
$1.51
24時間の取引高:
6.55M
Relative Volume:
2.00
時価総額:
$343.84M
収益:
$95,000
当期純損益:
$-327.27M
株価収益率:
-0.7217
EPS:
-2.12
ネットキャッシュフロー:
$-239.25M
1週間 パフォーマンス:
-2.55%
1か月 パフォーマンス:
+10.87%
6か月 パフォーマンス:
+2.00%
1年 パフォーマンス:
-20.73%
1日の値動き範囲:
Value
$1.49
$1.62
1週間の範囲:
Value
$1.46
$1.83
52週間の値動き範囲:
Value
$0.8621
$3.78

Allogene Therapeutics Inc Stock (ALLO) Company Profile

Name
名前
Allogene Therapeutics Inc
Name
セクター
Healthcare (1113)
Name
電話
(650) 457-2700
Name
住所
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Name
職員
361
Name
Twitter
@AllogeneTx
Name
次回の収益日
2025-05-02
Name
最新のSEC提出書
Name
ALLO's Discussions on Twitter

ALLO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ALLO
Allogene Therapeutics Inc
1.53 339.34M 95,000 -327.27M -239.25M -2.12
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.17 120.98B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
771.25 80.15B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
864.42 51.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
354.75 47.74B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
336.16 37.38B 4.98B 69.59M 525.67M 0.5197

Allogene Therapeutics Inc Stock (ALLO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-01-09 アップグレード Citizens JMP Mkt Perform → Mkt Outperform
2025-10-10 ダウングレード JP Morgan Neutral → Underweight
2025-05-14 ダウングレード Citizens JMP Mkt Outperform → Mkt Perform
2025-03-14 アップグレード Citizens JMP Mkt Perform → Mkt Outperform
2024-08-08 再開されました Oppenheimer Outperform
2024-05-31 開始されました Piper Sandler Overweight
2024-01-05 ダウングレード Guggenheim Buy → Neutral
2024-01-05 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2023-12-08 開始されました Citigroup Buy
2023-06-26 再開されました Oppenheimer Outperform
2023-03-21 開始されました Bernstein Mkt Perform
2023-01-24 アップグレード JP Morgan Neutral → Overweight
2023-01-06 アップグレード Robert W. Baird Neutral → Outperform
2022-12-12 ダウングレード BofA Securities Buy → Underperform
2022-08-10 ダウングレード Raymond James Outperform → Mkt Perform
2022-07-15 アップグレード Goldman Neutral → Buy
2022-06-03 開始されました Robert W. Baird Neutral
2022-02-28 繰り返されました B. Riley Securities Buy
2021-10-20 開始されました Cowen Outperform
2021-10-08 ダウングレード Goldman Buy → Neutral
2021-10-08 ダウングレード Stifel Buy → Hold
2021-09-23 アップグレード Raymond James Mkt Perform → Outperform
2021-06-21 再開されました Jefferies Buy
2021-05-20 アップグレード Truist Hold → Buy
2021-05-14 開始されました B. Riley Securities Buy
2021-01-26 アップグレード Stifel Hold → Buy
2020-12-10 再開されました H.C. Wainwright Buy
2020-11-24 開始されました BofA Securities Buy
2020-10-23 開始されました RBC Capital Mkts Outperform
2020-06-01 ダウングレード Raymond James Outperform → Mkt Perform
2020-05-29 繰り返されました H.C. Wainwright Buy
2020-05-19 アップグレード ROTH Capital Neutral → Buy
2020-05-15 アップグレード Guggenheim Neutral → Buy
2020-05-14 繰り返されました H.C. Wainwright Buy
2020-05-14 ダウングレード SunTrust Buy → Hold
2020-04-13 開始されました SunTrust Buy
2020-03-13 開始されました H.C. Wainwright Buy
2020-03-05 開始されました Stifel Hold
2020-02-24 開始されました Berenberg Hold
2019-12-18 開始されました JMP Securities Mkt Outperform
2019-11-04 開始されました Canaccord Genuity Buy
2019-08-09 開始されました BTIG Research Buy
2019-06-05 開始されました ROTH Capital Neutral
2019-05-31 開始されました Guggenheim Neutral
2019-05-23 開始されました Stifel Hold
2019-03-29 開始されました Piper Jaffray Overweight
すべてを表示

Allogene Therapeutics Inc (ALLO) 最新ニュース

pulisher
Jan 26, 2026

Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jan 26, 2026
pulisher
Jan 23, 2026

Insider Selling: Allogene Therapeutics (NASDAQ:ALLO) EVP Sells 26,269 Shares of Stock - MarketBeat

Jan 23, 2026
pulisher
Jan 21, 2026

Take Profit: What are the future prospects of Allogene Therapeutics IncBear Alert & Weekly Momentum Stock Picks - baoquankhu1.vn

Jan 21, 2026
pulisher
Jan 16, 2026

Allogene Therapeutics Positions 2026 as a Program-Defining Year for Scalable, Real-World Allogeneic CAR T - ADVFN

Jan 16, 2026
pulisher
Jan 15, 2026

Insider Trends: What are the future prospects of Allogene Therapeutics IncTrade Risk Report & Fast Moving Stock Watchlists - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 15, 2026

Decliners Report: Is AMZE part of any ETF2025 Winners & Losers & Safe Entry Zone Tips - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 13, 2026

Earnings Miss: Is Allogene Therapeutics Inc stock a top momentum play - Bộ Nội Vụ

Jan 13, 2026
pulisher
Jan 13, 2026

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Jan 13, 2026
pulisher
Jan 12, 2026

Sell Signal: What are the risks of holding Allogene Therapeutics Inc2025 Technical Overview & Reliable Volume Spike Trade Alerts - baoquankhu1.vn

Jan 12, 2026
pulisher
Jan 12, 2026

Earnings Risk: Will Allogene Therapeutics Inc stock hit new highs in YEARJobs Report & Weekly Market Pulse Alerts - baoquankhu1.vn

Jan 12, 2026
pulisher
Jan 11, 2026

Allogene Therapeutics Sees Bright Prospects with Upgrades and Awards - StocksToTrade

Jan 11, 2026
pulisher
Jan 11, 2026

Allogene Therapeutics Sees Optimistic Outlook as Market Interest Grows - timothysykes.com

Jan 11, 2026
pulisher
Jan 11, 2026

Allogene Therapeutics Stock Surges After Promising Market Developments - timothysykes.com

Jan 11, 2026
pulisher
Jan 10, 2026

Allogene Therapeutics’ Stock Surges as Analysts Optimistic on Future Outlook - StocksToTrade

Jan 10, 2026
pulisher
Jan 10, 2026

Allogene Therapeutics Stock Rises Amid Key Developments - StocksToTrade

Jan 10, 2026
pulisher
Jan 10, 2026

Allogene Therapeutics Stock Upgraded as ALPHA3 Trial Inspires Market Confidence - timothysykes.com

Jan 10, 2026
pulisher
Jan 10, 2026

Allogene Therapeutics Surges on Positive Analyst Ratings and Arbitration Wins - timothysykes.com

Jan 10, 2026
pulisher
Jan 10, 2026

Are Medical Stocks Lagging Allogene Therapeutics (ALLO) This Year? - sharewise.com

Jan 10, 2026
pulisher
Jan 09, 2026

Allogene Therapeutics (ALLO) Upgraded by Citizens to Market Outp - GuruFocus

Jan 09, 2026
pulisher
Jan 09, 2026

Allogene Therapeutics falls after trial delay, rating downgrade post Q1 results - MSN

Jan 09, 2026
pulisher
Jan 09, 2026

Citizens Upgrades Allogene Therapeutics (ALLO) - Nasdaq

Jan 09, 2026
pulisher
Jan 09, 2026

Allogene Therapeutics (ALLO) Upgraded to Outperform with Significant Upside - GuruFocus

Jan 09, 2026
pulisher
Jan 09, 2026

Allogene upgraded at Citizens on discounted EPS, revenue multiple - Seeking Alpha

Jan 09, 2026
pulisher
Jan 09, 2026

CG Oncology, Rich Sparkle Holdings, Liquidia And Other Big Stocks Moving Higher On Friday - Benzinga

Jan 09, 2026
pulisher
Jan 09, 2026

Allogene Therapeutics (NASDAQ:ALLO) Upgraded at Citizens Jmp - MarketBeat

Jan 09, 2026
pulisher
Jan 09, 2026

Allogene Therapeutics (NASDAQ:ALLO) Upgraded to Strong-Buy at UBS Group - MarketBeat

Jan 09, 2026
pulisher
Jan 09, 2026

Citizens upgrades Allogene stock rating to Market Outperform on cancer therapy potential - Investing.com

Jan 09, 2026
pulisher
Jan 09, 2026

Allogene In Focus: Can ALLO-316 Signal The Breakthrough CAR T Has Been Waiting For In Solid Tumors? - RTTNews

Jan 09, 2026
pulisher
Jan 08, 2026

Why Allogene Therapeutics Inc. stock is favored by pension fundsWeekly Profit Report & Free AI Powered Buy and Sell Recommendations - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Is Allogene Therapeutics Inc. stock a buy before product launchesRate Hike & Smart Money Movement Tracker - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Published on: 2026-01-08 23:56:20 - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will Allogene Therapeutics Inc. stock reach Wall Street targetsJuly 2025 Decliners & Fast Gain Stock Trading Tips - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Can Allogene Therapeutics Inc. stock outperform in 2025 bull market2025 Major Catalysts & Risk Managed Trade Strategies - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

How Allogene Therapeutics Inc. stock reacts to bond yieldsEarnings Growth Report & Consistent Profit Trade Alerts - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Allogene outlines 2026 clinical milestones for off-the-shelf CAR T - Investing.com India

Jan 08, 2026
pulisher
Jan 08, 2026

Allogene Therapeutics, Inc. Positions 2026 as Program-Defining Year for Scalable, Real-World Allogeneic CAR T - marketscreener.com

Jan 08, 2026
pulisher
Jan 08, 2026

Allogene Therapeutics interim futility analysis of MRD clearance from phase 2 Alpha3 trial planned for early Q2 2026 - marketscreener.com

Jan 08, 2026
pulisher
Jan 08, 2026

Allogene outlines 2026 clinical milestones for off-the-shelf CAR T By Investing.com - Investing.com South Africa

Jan 08, 2026
pulisher
Jan 08, 2026

Is Allogene Therapeutics Inc. stock a buy in volatile marketsQuarterly Earnings Review & Access Risk Ratings for Every Stock - Улправда

Jan 08, 2026
pulisher
Jan 07, 2026

UBS Initiates Coverage of Allogene Therapeutics (ALLO) with Buy Recommendation - Nasdaq

Jan 07, 2026
pulisher
Jan 07, 2026

UBS Initiates Coverage on Allogene Therapeutics (ALLO) with 'Buy' Rating | ALLO Stock News - GuruFocus

Jan 07, 2026
pulisher
Jan 07, 2026

UBS initiates coverage on Allogene stock with Buy rating, $8 price target By Investing.com - Investing.com South Africa

Jan 07, 2026
pulisher
Jan 07, 2026

UBS initiates coverage on Allogene stock with Buy rating, $8 price target - Investing.com Canada

Jan 07, 2026
pulisher
Jan 06, 2026

Allogene Therapeutics (NASDAQ:ALLO) Trading 4.4% HigherHere's Why - MarketBeat

Jan 06, 2026
pulisher
Jan 02, 2026

Allogene stock hits 52-week low at $1.76 amid market challenges - MSN

Jan 02, 2026
pulisher
Dec 31, 2025

Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Allogene Therapeutics (ALLO) - The Globe and Mail

Dec 31, 2025
pulisher
Dec 21, 2025

Is Allogene Therapeutics Inc. stock attractive for growth ETFsQuarterly Growth Report & Real-Time Volume Spike Alerts - Улправда

Dec 21, 2025

Allogene Therapeutics Inc (ALLO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$99.82
price up icon 2.09%
$103.47
price up icon 0.87%
$34.40
price up icon 2.78%
$119.34
price up icon 1.14%
$162.64
price up icon 1.83%
biotechnology ONC
$336.16
price down icon 0.48%
大文字化:     |  ボリューム (24 時間):